Cargando…

Tumour microenvironment in pheochromocytoma and paraganglioma

Pheochromocytomas and Paragangliomas (Pheo/PGL) are rare catecholamine-producing tumours derived from adrenal medulla or from the extra-adrenal paraganglia respectively. Around 10–15% of Pheo/PGL develop metastatic forms and have a poor prognosis with a 37% of mortality rate at 5 years. These tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Serena, Amore, Francesca, Canu, Letizia, Maggi, Mario, Rapizzi, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073672/ https://www.ncbi.nlm.nih.gov/pubmed/37033265 http://dx.doi.org/10.3389/fendo.2023.1137456

Ejemplares similares

Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts
por: Martinelli, Serena, et al.
Publicado: (2022)

Pheochromocytoma/paraganglioma preclinical models: which to use and why?
por: Martinelli, Serena, et al.
Publicado: (2020)

Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
por: De Filpo, Giuseppina, et al.
Publicado: (2023)

Correction: Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
por: De Filpo, Giuseppina, et al.
Publicado: (2023)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Clinical differences between small and large pheochromocytomas and paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
por: Wang, Xu, et al.
Publicado: (2023)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
por: Parenti, Gabriele, et al.
Publicado: (2012)

A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
por: Canu, Letizia, et al.
Publicado: (2021)

Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia
por: Provenzano, Aldesia, et al.
Publicado: (2022)

Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma
por: Wang, Yi, et al.
Publicado: (2022)

Genetic-Clinical Profile of Subjects with Apparently Sporadic Extra-Adrenal Paragangliomas
por: Ramundo, Valeria, et al.
Publicado: (2012)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study
por: Ma, Xiaosen, et al.
Publicado: (2020)

Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Cui, Yunying, et al.
Publicado: (2021)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
por: Jin, Bo, et al.
Publicado: (2022)

Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience
por: De Filpo, G., et al.
Publicado: (2021)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
por: Hanschell, Helena, et al.
Publicado: (2023)

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
por: Jimenez, Camilo
Publicado: (2018)

Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
por: Kim, Jung Hee, et al.
Publicado: (2022)

Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches
por: Kuo, Mickey J. M., et al.
Publicado: (2022)

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
por: Wang, Yuxiong, et al.
Publicado: (2023)

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective
por: Islam, Farhadul, et al.
Publicado: (2021)

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients
por: Yamazaki, Yuto, et al.
Publicado: (2020)

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World
por: Patel, Mayank, et al.
Publicado: (2021)

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
por: Zheng, Lei, et al.
Publicado: (2021)

Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
por: Park, Hyojung, et al.
Publicado: (2021)

Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma—Experiences From the GPOH-MET Registry
por: Kuhlen, Michaela, et al.
Publicado: (2022)

Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study
por: Zhao, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn4etd1cq4l52bkq4sbvpb34j8